calibration curve range [Bioanalytics]

posted by ritesh.korat.pharma – India, 2016-02-26 20:35 (3764 d 06:04 ago) – Posting: # 16032
Views: 10,493

Dear Ladi

To satisfy EMEA guideline which states that minimum two QC covered within Cmax of that particular period you can take following steps

Firstly monitor around 20% of first subject of the study. if Cmax of both periods of that subjects (at least 67% among them) will cross two QC than no need of additional QC and if its not cross than add one more QC between LQC and MQC. The all procedure must be incorporated in SOP prior to analysis

E.g. if you have to perform analysis of 100 subjects then you can monitor first twenty subjects among them

20% of 100 subjects is 20

if Cmax of both period in 14 (67% of 20) subjects out of that 20 subjects cross two QC level than no need of additional QC and if its not than add one more QC between LQC and MQC. so, in remaining subjects cmax cross two QC levels

Regards,
Ritesh Korat

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
171 visitors (0 registered, 171 guests [including 18 identified bots]).
Forum time: 03:40 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5